Ortivus launched CoroNet in Italy and Spain

OrtivusFollowing the successful launch of CoroNet in Sweden, Ortivus now continues to build up its international sales of the system. Two of the most important markets in Europe are Italy and Spain where Ortivus now signs a partner agreement with the well-reputed and market leading company et medical devices - cardiette - CARDIOLINE.

The company, with main office in Milano, and its own subsidiaries in Spain has about 110 employees and a turnover of approximately 15 million Euro. Under the well-known brand "CARDIOLINE" et medical devices develops and promotes products such as ECG, HOLTER and STRESS-TEST solution and has a market share in Italy of approximately 40%. The company has an extensive network in Italy and Spain of cardiologists and other strategically relevant target groups for Ortivus products. In order to fully leverage on the brand recognition on the market CoroNet will be promoted under the co-brand "CARDIOLINE CoroNet".

"In et medical devices Ortivus have found a partner with a well established customer network of the kind Ortivus addresses with CoroNet. They have an organization, market presence and know-how, which fit excellent with our requirements. Furthermore, et medical's strategic decision to enlarge their portfolio with a dedicated cardiac monitoring system like CoroNet shows a top-level commitment and involvement which I believe will pay-off for both parties. We truly look forward to working together with et medical.", says Rain Eriksoo, VP Sales & Marketing at Ortivus.

"CoroNet is a strategic and hence very important addition to our overall product offering. We have scanned the market for a suitable monitoring solution to complete our portfolio and CoroNet, not only being a monitoring system but a highly innovative solution that brings an extra value to our offer and our customers is exactly what we have been looking for. With CoroNet in our portfolio we can offer our customers solutions that cover all parts of cardiology related care and improve the dissemination of our brand CARDIOLINE in the cardiology arena.", says Gian-Luca Ziliani, Marketing and Business Development Manager of et medical devices.

CoroNet is a patient monitoring system developed to specifically target hospitals and departments in the need of advanced cardiac monitoring and rehabilitation. CoroNet innovatively combines bedside and telemetry monitoring into a single seamless system. The solution has already gained a strong market share in Sweden: Karolinska in Stockholm, The University Hospital of Sahlgrenska in Gothenburg and The Academic Hospital in Uppsala are examples of prestigious hospitals that have selected Ortivus' system for their cardiology departments.

About Ortivus
Ortivus AB is a Healthcare IT company that offers information and decision-making support systems for Healthcare, Emergency Medical Services and Public Safety in Europe and North America. Ortivus AB is listed on the OMX Nordic Exchange Small Cap list and was established in 1985. Ortivus has approximately 165 employees and subsidiaries in Denmark, Germany, Great Britain, Canada, and the US. For further information please visit www.ortivus.com

About et medical Devices
et medical devices - cardiette - CARDIOLINE are highly specialized in the development, production, marketing and worldwide sales of cardiovascular technologies. The main solutions provided are integrated ECG recorders, Stress Test Systems, Holter ECG, ABPM, Defibrillators, Monitors, Rehabilitation, Selfhomecare, Telemedicine and Information Management Software. New dedicated research and development programs are progressively enlarging the products portfolio with especially patient oriented solutions. For further information please visit www.cardiette.biz www.cardioline.biz

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Fine-Tuned LLMs Boost Error Detection in…

A type of artificial intelligence (AI) called fine-tuned large language models (LLMs) greatly enhances error detection in radiology reports, according to a new study published in Radiology, a journal of...

DeepSeek-R1 Offers Promising Potential t…

A joint research team from The Hong Kong University of Science and Technology and The Hong Kong University of Science and Technology (Guangzhou) has published a perspective article in MedComm...

Deep Learning can Predict Lung Cancer Ri…

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference...